BindingDB logo
myBDB logout

null

SMILES: COc1ccc(NC(=O)N2CCN(CCc3ccc(F)cc3)CC2)cc1-c1c(Cl)cnn1C

InChI Key: InChIKey=XKHWMPOANMCBHS-UHFFFAOYSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50324543   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
5-hydroxytryptamine receptor 2A


(Homo sapiens (Human))
BDBM50324543
PNG
(CHEMBL1215725 | N-[3-(4-Chloro-1-methyl-1H-pyrazol...)
Show SMILES COc1ccc(NC(=O)N2CCN(CCc3ccc(F)cc3)CC2)cc1-c1c(Cl)cnn1C |(-7.16,5.97,;-7.15,4.43,;-5.82,3.66,;-4.5,4.43,;-3.16,3.67,;-3.15,2.12,;-1.82,1.35,;-.48,2.12,;-.49,3.66,;.85,1.35,;2.17,2.13,;3.51,1.35,;3.51,-.19,;4.84,-.96,;6.17,-.19,;7.5,-.97,;8.82,-.21,;10.15,-.97,;10.15,-2.52,;11.48,-3.29,;8.82,-3.29,;7.49,-2.51,;2.17,-.96,;.84,-.19,;-4.49,1.35,;-5.82,2.12,;-7.16,1.35,;-7.09,-.18,;-5.81,-1.03,;-8.54,-.72,;-9.49,.49,;-8.64,1.77,;-9.17,3.22,)|
Show InChI InChI=1S/C24H27ClFN5O2/c1-29-23(21(25)16-27-29)20-15-19(7-8-22(20)33-2)28-24(32)31-13-11-30(12-14-31)10-9-17-3-5-18(26)6-4-17/h3-8,15-16H,9-14H2,1-2H3,(H,28,32)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
PubMed
155n/an/an/an/an/an/an/an/a



Arena Pharmaceuticals.

Curated by ChEMBL


Assay Description
Displacement of [125I]DOI from human recombinant 5HT2A receptor expressed in HEK293 cells after 1 hr by scintillation counting


J Med Chem 53: 5696-706 (2010)


Article DOI: 10.1021/jm100479q
BindingDB Entry DOI: 10.7270/Q2CV4HZX
More data for this
Ligand-Target Pair
5-hydroxytryptamine receptor 2C


(Homo sapiens (Human))
BDBM50324543
PNG
(CHEMBL1215725 | N-[3-(4-Chloro-1-methyl-1H-pyrazol...)
Show SMILES COc1ccc(NC(=O)N2CCN(CCc3ccc(F)cc3)CC2)cc1-c1c(Cl)cnn1C |(-7.16,5.97,;-7.15,4.43,;-5.82,3.66,;-4.5,4.43,;-3.16,3.67,;-3.15,2.12,;-1.82,1.35,;-.48,2.12,;-.49,3.66,;.85,1.35,;2.17,2.13,;3.51,1.35,;3.51,-.19,;4.84,-.96,;6.17,-.19,;7.5,-.97,;8.82,-.21,;10.15,-.97,;10.15,-2.52,;11.48,-3.29,;8.82,-3.29,;7.49,-2.51,;2.17,-.96,;.84,-.19,;-4.49,1.35,;-5.82,2.12,;-7.16,1.35,;-7.09,-.18,;-5.81,-1.03,;-8.54,-.72,;-9.49,.49,;-8.64,1.77,;-9.17,3.22,)|
Show InChI InChI=1S/C24H27ClFN5O2/c1-29-23(21(25)16-27-29)20-15-19(7-8-22(20)33-2)28-24(32)31-13-11-30(12-14-31)10-9-17-3-5-18(26)6-4-17/h3-8,15-16H,9-14H2,1-2H3,(H,28,32)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
PubMed
>1.00E+4n/an/an/an/an/an/an/an/a



Arena Pharmaceuticals.

Curated by ChEMBL


Assay Description
Displacement of [125I]DOI from human recombinant 5HT2C receptor expressed in HEK293 cells after 1 hr by scintillation counting


J Med Chem 53: 5696-706 (2010)


Article DOI: 10.1021/jm100479q
BindingDB Entry DOI: 10.7270/Q2CV4HZX
More data for this
Ligand-Target Pair